Japanese presenters on cardiocell also? where did the tokyo hospital get these? Asian approval and canadian, oz approvals to come soon I gather.
Our medico expert on our team says that another potential adapt tissue use is cancer surgery, replacement tissue to replace cut out benign tumours instaed of radiotherapy, oncological adapt applications may be body wide, in many cases they need triple surgeries to repair cancer cut out tissues just for the tissue replacement thats calcified. This may cause tissue stimulus to create recurrence of removed cancer in surrounding cells that may have some cancerous cells remaining.
other usesmay also be trauma repair, gunshot or car accident wound surgery, most trauma deaths a rise from inability to stem arterial blood loss, so they pump the blood in but like a leaking tyre it spurts out elsewhere, if it can be patched then the blood loss can be reduced dramatically.
terry you got our minds buzzing now with all the human biological uses for adapt and cardiocel. As I said it may be limitless, stem cells can grow onto this tissue and regenerate organs, any organ you want, even complex ones like lungs, liver, kidneys using patient stem cell or compatible donated dna.
The EACTS conference is just the start... the germans and dutch are leading this move and the trumpets accross eirope are loud and clear..come and get thembest surgical biotech tissue in the world ..you dont need to do repeat surgeries for 6 years! You can focus on the actual cause instead of fixing the remedy.
I can hear those trumpets from the european capitals..its spreading globally like wildfire... the specialists will lead the way, little ole ahz is on a global winner.
- Forums
- ASX - By Stock
- Ann: Admedus to showcase CardioCel at EACTS Annual Meeting
Japanese presenters on cardiocell also? where did the tokyo...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.48 |
Change
-0.020(0.17%) |
Mkt cap ! $242.6M |
Open | High | Low | Value | Volume |
$11.50 | $11.50 | $10.91 | $152.9K | 13.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 257 | $11.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.50 | 4416 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 257 | 11.100 |
1 | 631 | 11.000 |
1 | 150 | 10.920 |
1 | 46 | 10.910 |
1 | 48 | 10.900 |
Price($) | Vol. | No. |
---|---|---|
11.500 | 4416 | 1 |
11.830 | 500 | 1 |
11.850 | 164 | 1 |
11.900 | 1000 | 1 |
12.100 | 500 | 1 |
Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online